1. Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China;
2. Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China;
3. Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China;
4. Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
5. Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China; and
6. Shanghai World Foreign Language Academy, Shanghai, China